January 12, 2016 — A Senate health committee on Tuesday easily advanced the nomination of former Duke University researcher and cardiologist Robert Califf as the next commissioner of the Food and Drug Administration. But Califf, while widely expected to win confirmation from the full Senate, faces at least one surprise hurdle on the way to his new job: genetically engineered salmon.
Sen. Lisa Murkowski (R-Alaska) told her colleagues on the committee that met Tuesday to vote on Califf’s nomination that she is willing to stall it until he and FDA agree to mandatory labeling requirements for the AquaAdvantage salmon.
The salmon, produced by Massachusetts-based AquaBounty and approved by the agency in November, is an Atlantic salmon that contains a growth hormone from a Chinook salmon and has been given a gene from the ocean pout, an eel-like fish. The result is a fish engineered to grow twice as fast as its natural counterpart. The first genetically altered animal approved for human consumption, it has been the subject of long-running fights involving food-safety activists, environmental groups and the salmon fishing industry.